Skip to main content

Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
7.65 -0.22 (-2.80%)
Oct 22, 2021 11:39 AM EDT - Market closed
Market Cap211.75M
Revenue (ttm)76.97M
Net Income (ttm)-31.74M
Shares Out27.73M
EPS (ttm)-1.74
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,336
Open7.84
Previous Close7.87
Day's Range7.41 - 7.84
52-Week Range6.52 - 31.99
Betan/a
AnalystsStrong Buy
Price Target23.33 (+205.0%)
Est. Earnings DateNov 9, 2021

About BDSX

Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests that provide physicians with timely results to facilitate treatment decisions. It also provides Bio-Rad SARS-CoV-2 ddPCR test, which is designed to detect the presence of infection by ...

IndustryDiagnostics & Research
IPO DateOct 28, 2020
Employees200
Stock ExchangeNASDAQ
Ticker SymbolBDSX
Full Company Profile

Financial Performance

In 2020, Biodesix's revenue was $45.56 million, an increase of 85.55% compared to the previous year's $24.55 million. Losses were -$31.35 million, 2.03% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for Biodesix stock is "Strong Buy." The 12-month stock price forecast is 23.33, which is an increase of 204.97% from the latest price.

Price Target
$23.33
(204.97% upside)
Analyst Consensus: Strong Buy

News

Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur a...

1 week ago - Business Wire

Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstrac...

1 month ago - Business Wire

Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Ch...

1 month ago - Business Wire

Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American ...

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX). Today Biodesix announced that the Accreditation Committee of the College of American Pathologists (CAP) and Briti...

1 month ago - Business Wire

4 Stocks Insiders Are Buying

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.

Other symbols:DNUTETSIX
1 month ago - Benzinga

Biodesix Announces Second Quarter 2021 Results and Highlights

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial an...

2 months ago - Business Wire

Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of ...

2 months ago - Business Wire

Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will rel...

2 months ago - Business Wire

Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. (NASDAQ: SEER)...

Other symbols:SEER
4 months ago - Business Wire

Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the broad commer...

4 months ago - Business Wire

Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank

BOULDER, Colo. & SAN FRANCISCO--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading lung cancer diagnostic solutions company, announced a strategic partnership with Datava...

4 months ago - Business Wire

Biodesix to Present at the William Blair 41st Annual Growth Stock Conference

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Ch...

4 months ago - Business Wire

Biodesix Announces First Quarter 2021 Results

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced financial and op...

5 months ago - Business Wire

Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, has announced their plan to add ...

5 months ago - Business Wire

Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Comme...

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced in partnership w...

5 months ago - Business Wire

Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will rel...

5 months ago - Business Wire

Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management

BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Pulmonary disease expert, Dr. Susan Garwood, is hosted by CHEST to discuss standardized risk assessment to inform lung nodule management

6 months ago - Business Wire

Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Pati...

BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Biodesix releases new data at AACR annual meeting on the use of proteomic profiling to help guide physician treatment strategies for NSCLC patients.

6 months ago - Business Wire

Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Pa...

BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Biodesix receives two important U.S. patents for diagnostic methods, which seek to improve care for cancer patients.

6 months ago - Business Wire

Biodesix Announces Closing of New $30 Million Term Loan

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix announces the closing of a $30 million term loan.

6 months ago - Business Wire

Biodesix Announces Fourth Quarter and Full Year 2020 Results

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix releases fourth quarter and full year 2020 results

7 months ago - Business Wire

Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021

BOULDER, Colo.--(BUSINESS WIRE)-- #BDSX--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial re...

7 months ago - Business Wire

Biodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021

BOULDER, Colo.--(BUSINESS WIRE)-- #BDSX--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Re...

7 months ago - Business Wire

Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with Chica...

8 months ago - Business Wire